Suchergebnisse - "White, Nicholas J"

PubPharm (1.661)

11

Transmission-blocking activity of artesunate, chloroquine and methylene blue onPlasmodium vivaxgametocytes

enthalten in: bioRxiv.org | 2024

von Chaumeau, V. | Wasisakun, P. | Watson, J. | +11

12

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria-authors' response

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Saralamba, S. | Simpson, J. | White, N.

CommentOn: J Antimicrob Chemother. 2023 Sep 5;78(9):2192-2202. - PMID 37473441

13

The relationship between viral clearance rates and disease progression in early symptomatic COVID-19 : a systematic review and meta-regression analysis

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Singh, S. | Boyd, S. | Schilling, W. | +3

14

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria : An individual patient data meta-analysis'

enthalten in: eLife | 2024

von Watson, J. | Commons, R. | Tarning, J. | +10

15

Primaquine in glucose-6-phosphate dehydrogenase deficiency : an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers

enthalten in: eLife | 2024

von Pukrittayakamee, S. | Jittamala, P. | Watson, J. | +10

16

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax : a systematic review and individual patient data meta-analysis

enthalten in: The Lancet. Infectious diseases | 2024

von Commons, R. | Rajasekhar, M. | Edler, P. | +57

17

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria : a systematic review and individual patient data meta-analysis

enthalten in: The Lancet. Infectious diseases | 2024

von Rajasekhar, M. | Simpson, J. | Ley, B. | +50

18

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar

enthalten in: ResearchSquare.com | 2024

von Thu, A. | Phyo, A. | Pateekhum, C. | +19

19

Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)

enthalten in: bioRxiv.org | 2024

von Jittamala, P. | Boyd, S. | Schilling, W. | +40

20

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial

enthalten in: ResearchSquare.com | 2024

von Luvira, V. | Schilling, W. | Jittamala, P. | +32